The Many Ethical Implications of Emerging Technologies
By Nayef Al-Rodhan,
Scientific American
| 03. 13. 2015
Untitled Document
In the past four decades technology has fundamentally altered our lives: from the way we work to how we communicate to how we fight wars. These technologies have not been without controversy, and many have sparked intense debates that are often polarized or embroiled in scientific ambiguities or dishonest demagoguery.
The debate on stem cells and embryo research, for example, has become a hot-button political issue involving scientists, policy makers, politicians and religious groups. Similarly, the discussions on genetically modified organisms (GMOs) have mobilized civil society, scientists and policy makers in a wide debate on ethics and safety. The developments in genome-editing technologies are just one example that bioresearch and its impact on market goods are strongly dependent on social acceptance and cannot escape public debates of regulation and ethics. Moreover, requests for transparency are increasingly central to these debates, as shown by movements like Right to Know, which has repeatedly demanded the labeling of GMOs on food products.
Ethical and regulatory challenges
On March 4 the World Economic Forum released its list of the top...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...